Ticker · CUSIP 10806X102

BBIO

BRIDGEBIO PHARMA INC
···Share
Holders (tracked)
16
Combined shares
27,983,474
Combined value
$1.85B
Last close
$77.51
Quarter
2025Q4
Tracked holders · last 8 quarters
+5 vs previous quarter over the last 8.
16152024Q12025Q4
Price is +17.4% vs the avg quarter-end implied price across tracked holders.

SEC event timeline

30 events
  1. Kumar Neil · Chief Executive Officer
    2026-04-10
    Sold $1.49M @ $74.60
    Insider sell
  2. Kumar Neil · Chief Executive Officer
    2026-04-10
    Sold $1.49M @ $74.60
    Insider sell
  3. Kumar Neil · Chief Executive Officer
    2026-04-09
    Sold $530.2K @ $73.64
    Insider sell
  4. Kumar Neil · Chief Executive Officer
    2026-04-09
    Sold $395.4K @ $74.60
    Insider sell
  5. Kumar Neil · Chief Executive Officer
    2026-04-09
    Sold $566.7K @ $75.55
    Insider sell
  6. Kumar Neil · Chief Executive Officer
    2026-04-09
    Sold $520.8K @ $73.64
    Insider sell
  7. Kumar Neil · Chief Executive Officer
    2026-04-09
    Sold $382.4K @ $74.57
    Insider sell
  8. Kumar Neil · Chief Executive Officer
    2026-04-09
    Sold $589.1K @ $75.53
    Insider sell
  9. +12,600 shares · 2025Q4
    13F
  10. +698,182 shares · 2025Q4
    13F
  11. −38,731 shares · 2025Q4
    13F
  12. +35,690 shares · 2025Q4
    13F
  13. −1,583,915 shares · 2025Q4
    13F
  14. −381,894 shares · 2025Q4
    13F
  15. −133,852 shares · 2025Q4
    13F
  16. +7,600 shares · 2025Q4
    13F
  17. +1,329,537 shares · 2025Q4
    13F
  18. +2,261,181 shares · 2025Q4
    13F
  19. +43,172 shares · 2025Q4
    13F
  20. −322,246 shares · 2025Q4
    13F
  21. +1,527,028 shares · 2025Q4
    13F
  22. +232,401 shares · 2025Q4
    13F
  23. −124,068 shares · 2025Q3
    13F
  24. −58,978 shares · 2025Q3
    13F
  25. −450,021 shares · 2025Q3
    13F
  26. −10,126 shares · 2025Q3
    13F
  27. +171,509 shares · 2025Q3
    13F
  28. −2,577,526 shares · 2025Q3
    13F
  29. +606,349 shares · 2025Q3
    13F
  30. +962,525 shares · 2025Q3
    13F

Insider activity

Last 30 days
Net (open-market)
−$5.97M
Buys
0 · $0
Sells
8 · $5.97M
Unique insiders
1
DateInsiderCodeSharesPriceValue
04-10Kumar Neil
Chief Executive Officer · Officer, Director
S20,000$74.60$1.49M
04-10Kumar Neil
Chief Executive Officer · Officer, Director
S20,000$74.60$1.49M
04-09Kumar Neil
Chief Executive Officer · Officer, Director
S7,200$73.64$530.2K
04-09Kumar Neil
Chief Executive Officer · Officer, Director
S5,300$74.60$395.4K
04-09Kumar Neil
Chief Executive Officer · Officer, Director
S7,500$75.55$566.7K
04-09Kumar Neil
Chief Executive Officer · Officer, Director
S7,072$73.64$520.8K
04-09Kumar Neil
Chief Executive Officer · Officer, Director
S5,128$74.57$382.4K
04-09Kumar Neil
Chief Executive Officer · Officer, Director
S7,800$75.53$589.1K
Follow-the-investor returns
If you'd copied each holder of BBIO…
Cost basis inferred from 13F share-delta history. Sorted by % return on the position they're still holding.
InvestorFirst inCost basisReturnPosition value today
T. Rowe Price2020Q1$0.45+17114.4%$296.8M
Andreas Halvorsen (Viking Global)2019Q2$26.97+187.4%$1.12B
Steve Cohen (Point72)2019Q2$34.26+126.2%$295K
Steve Cohen (Point72)2019Q2$34.26+126.2%$295K
Two Sigma Investments2020Q3$38.01+103.9%$150.9M
Ken Fisher (Fisher Asset Mgmt)2021Q3$39.19+97.8%$18.0M
Paul Tudor Jones (Tudor Investment)2021Q2$42.13+84.0%$977K
D.E. Shaw & Co.2020Q1$42.83+81.0%$171.6M
AQR Capital Management2020Q2$43.69+77.4%$10.4M
Izzy Englander (Millennium Mgmt)2019Q2$49.27+57.3%$2.8M
Wellington Management2024Q1$65.33+18.6%$182.1M
Ken Griffin (Citadel Advisors)2020Q1$69.53+11.5%$8.6M
Ken Griffin (Citadel Advisors)2020Q1$69.53+11.5%$8.6M
Ken Griffin (Citadel Advisors)2020Q1$69.53+11.5%$8.6M
Ray Dalio (Bridgewater Associates)2025Q4$76.49+1.3%$3.3M
Norges Bank (Norway SWF)2019Q2$363.67-78.7%$118.4M

Who moved on this name in 2025Q4

13F transactions reported for the latest quarter, grouped by direction.
Added to3
Trimmed4
Exited1

Institutional ownership over time

Distinct super-investors holding this ticker · combined dollar value, by quarter.
QuarterHoldersCombined value
2022Q1
13
$11.57B
2022Q2
13
$9.14B
2022Q3
14
$10.0M
2022Q4
13
$372.2M
2023Q1
16
$736.6M
2023Q2
13
$756.5M
2023Q3
15
$1.10B
2023Q4
13
$1.62B
2024Q1
15
$1.30B
2024Q2
14
$1.14B
2024Q3
13
$801.8M
2024Q4
12
$817.5M
2025Q1
18
$943.7M
2025Q2
16
$1.16B
2025Q3
11
$1.18B
2025Q4
16
$1.85B
Congress members trading this stock
DateMemberTypeAmount rangeFiling
2026-03-19Gilbert CisnerosBuy$1K – $15KPDF ↗
2026-03-18Gilbert CisnerosBuy$1K – $15KPDF ↗
2026-03-03Gilbert CisnerosBuy$1K – $15KPDF ↗
2025-09-22Gilbert CisnerosBuy$1K – $15KPDF ↗
2025-08-08Gilbert CisnerosBuy$1K – $15KPDF ↗

Who owns BBIO

16 super-investors · 2025Q4
Tracked stake
27.98M
shares
Combined value
$1.85B
% of shares outstanding
shares-out unknown
Quarter action mix
New9Added3Trim4
#ManagerSharesValue
1Andreas Halvorsen
Viking Global
14.39M$1.10B
2Wellington Management2.35M$180M
3D.E. Shaw & Co.2.21M$169M
4Two Sigma Investments1.95M$149M
5Norges Bank
Norway SWF
1.53M$117M
6Ken Griffin
Citadel Advisors
698.2K$53M
7Ken Griffin
Citadel Advisors
447.5K$34M
8Ken Fisher
Fisher Asset Mgmt
232.4K$18M
9AQR Capital Management134.5K$10M
10Ken Griffin
Citadel Advisors
111.4K$9M
11Ray Dalio
Bridgewater Associates
43.2K$3M
12Izzy Englander
Millennium Mgmt
36.6K$3M
13Paul Tudor Jones
Tudor Investment
12.6K$964K
14T. Rowe Price3.83M$293K
15Steve Cohen
Point72
3.8K$291K
16Steve Cohen
Point72
3.8K$291K

Recent moves

20 transactions
Embed this chart
Paste this iframe anywhere to embed the live BBIO chart.
<iframe src="https://openstocks.me/embed/stock/BBIO" width="100%" height="480" frameborder="0" loading="lazy" title="BBIO chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>